RecruitingNot ApplicableNCT07012369

Written and Visual Messages on Sanitary Nap Packagig

The Effect of Written and Visual Messages on Sanitary Nap Packagig on Women's Knowledge and Attitudes Towards Family Planning: a Randomized Controlled Ctudy


Sponsor

Ondokuz Mayıs University

Enrollment

50 participants

Start Date

Jan 5, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Packaging plays an important role in consumers' orientation and purchase of any product. Warnings about the harms of smoking on cigarette packages give at least 7000 warnings per year for an addict who smokes a pack of cigarettes a day. This study was planned to determine the effects of written and visual messages on sanitary pad packaging on women's knowledge and attitudes towards family planning. The research was planned as a randomized controlled experimental study. The research will be conducted with women who come to the Family Health Centers of the Samsun Provincial Health Directorate in the Atakum district for the care and follow-up of their babies between January 2024 and January 2025. The research will be conducted with two groups as intervention and control groups. The sample size was calculated using the G\*Power 3.1.9.2 program and was found to be 39 for the intervention group and 39 for the control group. In order to increase the analytical power of the research, it was planned to increase the sample size by 30% and to include a total of 100 people (intervention group: 50 and control group: 50) with the non-probability sampling (random) method. Personal Information Form, Family Planning Information Form and Family Planning Attitude Scale will be used to collect data. In the first interview, the first section of the Personal Information Form will be filled in using the face-to-face interview technique, and the Family Planning Information Form and Family Planning Attitude Scale will be filled in according to the woman's own report. Three months after the first interview, the second section of the Introductory Information Form, the Family Planning Information Form and the Family Planning Attitude Scale will be filled in using the online survey form filling method. The women in the intervention group will be given two packages with written and visual messages about family planning (a total of 28 sanitary pads, 14 in one package). The women in the control group will not be given any materials. The data of the study will be evaluated using the Statistical Package for the Social Sciences 24 program. Descriptive statistics will be given, and for compliance with normal distribution, Kolmogorov-Smirnov will be used to evaluate, and for those that are not suitable, the Student t test, ANOVA test, paired two-sample t test, Mann-Whitney U, Kruskal Wallis test, Wilcoxon test, Friedman test will be used. The Type 1 error level will be taken as 0.05.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 49 Years

Inclusion Criteria10

  • Women who are at least primary school graduates,
  • Those who have a baby aged 9-18 months,
  • Those who do not use AP methods or traditional AP methods (withdrawal, Calendar method),
  • Those who are married and have a sexual partner,
  • Those who have an active sexual life,
  • Those who have a regular menstrual cycle,
  • Those who do not have any obstacles that prevent communication,
  • Those who are willing to give their phone number,
  • Those who use a smartphone,
  • Women who are at least primary school graduates will be included.

Exclusion Criteria8

  • Those who received family planning training in the postpartum period,
  • Those who use modern FP methods,
  • Those who underwent hysterectomy surgery due to complications such as bleeding in the postpartum period,
  • Those who have a history of infertility and became pregnant with assisted reproductive techniques,
  • Those who have any health problems (such as thyroid, cancer) that negatively affect the menstrual cycle,
  • Those who have any chronic diseases (such as cancer, diabetes, hypertension, hypercholesterolemia, heart disease, etc.) or use of medications (such as diuretics, antihypertensives, antihistamines, anticholinergics, etc.) that negatively affect sexual health,
  • Those who are pregnant or planning to get pregnant again,
  • Women who do not agree to participate in the study or who give up participating in the study or provide incorrect or incomplete information will not be included in the study.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERExperimental group: sanitary pads with messages about family planning on them

Sanitary pads with messages about family planning on them. Signing the Informed Consent Form, Filling in the first section of the data collection form, the Family Planning Information Form and the Family Planning Attitude Scale, Obtaining contact information, Giving 2 packages of sanitary pads (14 in each package, 28 in total) with messages about family planning methods, Notifying that contact will be made three months after the end of the first menstrual bleeding, Filling in the second section of the data collection form, the Family Planning Information Form and the Family Planning Attitude Scale, three months after the sanitary pads are given, Expressing gratitude for participating in the study and saying goodbye.

OTHERControl group: not be given any materials

Not be given any materials Signing the Informed Consent Form, Filling in the first section of the data collection form, the Family Planning Information Form and the Family Planning Attitude Scale, Obtaining contact information, Notifying that contact will be established three months after the end of the first menstrual bleeding, Filling in the second section of the data collection form, the Family Planning Information Form and the Family Planning Attitude Scale, three months after the sanitary pads are given, Expressing gratitude for participation in the study and saying goodbye,


Locations(1)

Ondokuz Mayıs University

Samsun, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07012369


Related Trials